1. Home
  2. DCBO vs DNA Comparison

DCBO vs DNA Comparison

Compare DCBO & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

HOLD

Current Price

$18.56

Market Cap

632.5M

Sector

N/A

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.45

Market Cap

607.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCBO
DNA
Founded
2016
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
632.5M
607.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DCBO
DNA
Price
$18.56
$9.45
Analyst Decision
Buy
Hold
Analyst Count
9
2
Target Price
$34.67
$10.50
AVG Volume (30 Days)
87.0K
879.7K
Earning Date
02-27-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
32.42
N/A
EPS
0.74
N/A
Revenue
$236,691,000.00
$180,606,000.00
Revenue This Year
$13.67
N/A
Revenue Next Year
$7.43
$3.07
P/E Ratio
$25.45
N/A
Revenue Growth
13.16
N/A
52 Week Low
$18.11
$5.00
52 Week High
$43.84
$17.58

Technical Indicators

Market Signals
Indicator
DCBO
DNA
Relative Strength Index (RSI) 26.21 50.60
Support Level $18.11 $8.82
Resistance Level $19.08 $11.10
Average True Range (ATR) 0.71 0.60
MACD -0.19 0.03
Stochastic Oscillator 8.86 29.39

Price Performance

Historical Comparison
DCBO
DNA

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: